FormFactor, Inc. Reports Second Quarter Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FormFactor, Inc. Reports Second Quarter Results

LIVERMORE, CA--(Marketwired - Jul 30, 2014) - FormFactor, Inc. ( NASDAQ : FORM ) today announced its financial results for the second quarter of fiscal 2014 that ended on June 28, 2014. Quarterly revenues were $67.4 million, up 20% from $56.0 million in the first quarter of fiscal 2014, and up 7% from $62.7 million in the second quarter of fiscal 2013.

On a GAAP basis, net loss for the second quarter of fiscal 2014 was $(4.3) million, or $(0.08) per fully-diluted share, compared to a net loss for the first quarter of fiscal 2014 of $(12.7) million, or $(0.23) per fully-diluted share, and a net loss for the second quarter of fiscal 2013 of $(8.4) million, or $(0.16) per fully-diluted share.

On a non-GAAP basis, net income for the second quarter of fiscal 2014 was $4.9 million, or $0.08 per fully-diluted share, compared to a net loss for the first quarter of fiscal 2014 of $(2.3) million, or $(0.04) per fully-diluted share, and a net loss for the second quarter of fiscal 2013 of $(0.3) million, or $(0.01) per fully-diluted share. A reconciliation of GAAP to non-GAAP net income (loss) and net income (loss) per share is provided in the schedules included below.

Cash generation for the second quarter of fiscal 2014 was $5.0 million, compared to cash usage of $(7.1) million for the first quarter of fiscal 2014 and cash generation of $1.0 million for the second quarter of fiscal 2013. 

"In Q2, we saw increased business and improved operational performance, resulting in our first non-GAAP profitable quarter since Q4 of 2007," said Tom St. Dennis, CEO of FormFactor, Inc. "We made significant progress in each of our DRAM, Flash Memory and SOC product lines during the quarter and are positioned to support our growth objectives through 2016."

The company has posted its revenue breakdown by region and market segment on the Investors section of its website at www.formfactor.com . FormFactor will conduct a conference call at 1:30 p.m. PDT, or 4:30 p.m. EDT, today.

The public is invited to listen to a live webcast of FormFactor's conference call on the Investors section of the company's web site at www.formfactor.com . A telephone replay of the conference call will be available approximately two hours after the conclusion of the call. The telephone replay will be available through August 1, 2014, 9:00 p.m. PDT, and can be accessed by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international) and entering confirmation code 73696070. Additionally, the replay will be available on the Investors section of our website, www.formfactor.com .

Non-GAAP Financial Measures :

This press release highlights the company's financial results on both a GAAP and a non-GAAP basis. The GAAP results include certain charges that are excluded from non-GAAP results. By publishing the non-GAAP measures, management intends to provide investors with additional information to further analyze the company's performance, core results and underlying trends. FormFactor's management evaluates results and makes operating decisions using both GAAP and non-GAAP measures included in this press release. Non-GAAP results are not prepared in accordance with GAAP, and non-GAAP information should be considered a supplement to, and not a substitute for, financial statements prepared in accordance with GAAP. Investors and potential investors are encouraged to review the reconciliation of non-GAAP financial measures to their most directly comparable GAAP measures attached to this press release.

About FormFactor:

FormFactor, Inc. ( NASDAQ : FORM ) helps semiconductor manufacturers test the integrated circuits (ICs) that power consumer mobile devices, as well as computing, automotive and other applications. The company is one of the world's leading providers of essential wafer test technologies and expertise, with an extensive portfolio of high-performance probe cards for DRAM, Flash and SoC devices. Customers use FormFactor's products and services to lower overall production costs, improve their yields and enable complex next-generation ICs. Headquartered in Livermore, California, the company services its customers from a network of facilities in Europe, Asia and North America. For more information, visit the company's website at www.formfactor.com .

FormFactor, MicroProbe, and the FormFactor and MicroProbe logos are registered or unregistered trademarks of FormFactor, Inc. All other product, trademark, company or service names mentioned herein are the property of their respective owners.

Forward-looking Statements :

Statements in this press release that are not strictly historical in nature are forward-looking statements within the meaning of the federal securities laws, including statements regarding anticipated results, market conditions or trends, expectations and operating plans. These forward-looking statements are based on current information and expectations that are inherently subject to change and involve a number of risks and uncertainties. Actual events or results might differ materially from those in any forward-looking statement due to various factors, including, but not limited to: unexpected changes in demand for the company's products; seasonal industry trends; risks of the company's ability to realize further operational efficiencies, to realize sustainable profitability, to achieve its growth objectives, and to meet customer demand for the company's DRAM, Flash Memory and SoC products; and changes in the market and macro-economic environments. Additional information concerning factors that could cause actual events or results to differ materially from those in any forward-looking statement is contained in the company's Form 10-K for the fiscal year ended December 28, 2013, as filed with the SEC, and subsequent SEC filings, including the company's Quarterly Reports on Forms 10-Q. Copies of the company's SEC filings are available at http://investors.formfactor.com/sec.cfm . The company assumes no obligation to update the information in this press release, to revise any forward-looking statements or to update the reasons actual results could differ materially from those anticipated in forward-looking statements.

FORM-F

   
   
FORMFACTOR, INC.  
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS  
(In thousands, except per share amounts)  
(Unaudited)  
   
    Three Months Ended     Six Months Ended  
    June 28, 2014     June 29, 2013     June 28, 2014     June 29, 2013  
Revenues   $ 67,352     $ 62,733     $ 123,311     $ 115,353  
Cost of revenues     47,328       46,328       90,962       89,873  
Gross profit     20,024       16,405       32,349       25,480  
Operating expenses:                                
  Research and development     11,074       10,915       20,821       21,844  
  Selling, general and administrative     13,191       13,487       25,445       28,105  
  Restructuring charges, net     59       92       2,056       4,072  
  Loss on sale of subsidiary     --       300       --       300  
  Impairment of long-lived assets     --       121       743       179  
    Total operating expenses     24,324       24,915       49,065       54,500  
Operating loss     (4,300 )     (8,510 )     (16,716 )     (29,020 )
Interest income, net     79       96       158       203  
Other income (expense), net     (156 )     209       (222 )     632  
Loss before income taxes     (4,377 )     (8,205 )     (16,780 )     (28,185 )
Provision (benefit) for income taxes     (51 )     202       257       (5 )
Net loss   $ (4,326 )   $ (8,407 )   $ (17,037 )   $ (28,180 )
Net loss per share:                                
  Basic and Diluted   $ (0.08 )   $ (0.16 )   $ (0.31 )   $ (0.52 )
Weighted-average number of shares used in per share calculations:                                
  Basic and diluted     55,812       54,105       55,431       53,886  
                                   
                                   
                                   
FORMFACTOR, INC.  
RECONCILIATION OF NON-GAAP NET INCOME (LOSS)  
(In thousands, except per share amounts)  
(Unaudited)  
   
    Three Months Ended     Six Months Ended  
    June 28, 2014     June 29, 2013     June 28, 2014     June 29, 2013  
GAAP net loss   $ (4,326 )   $ (8,407 )   $ (17,037 )   $ (28,180 )
Stock-based compensation     3,519       3,132       6,089       6,166  
Restructuring charges, net     59       92       2,056       4,072  
Acquisition and integration related expenses     388       282       429       1,194  
Amortization of intangibles, inventory and fixed assets fair value adjustment due to acquisition     4,953       4,206       9,902       8,992  
Impairment of long-lived assets     --       421       743       479  
Loss contingency     280       --       413       --  
Income tax valuation allowance     --       --       --       150  
Non-GAAP net income (loss)   $ 4,873     $ (274 )   $ 2,595     $ (7,127 )
                                 
Non-GAAP net income (loss) per share:                                
Basic   $ 0.09     $ (0.01 )   $ 0.05     $ (0.13 )
Diluted   $ 0.08     $ (0.01 )   $ 0.05     $ (0.13 )
                                 
Weighted-average number of shares used in per share calculations:                                
Basic     55,812       54,105       55,431       53,886  
Diluted     57,373       54,105       57,012       53,886  
                                 
                                 
                                 
FORMFACTOR, INC.  
CONDENSED CONSOLIDATED BALANCE SHEETS  
(In thousands)  
(Unaudited)  
   
    June 28, 2014     December 28, 2013  
ASSETS                
Current assets:                
  Cash and cash equivalents   $ 69,859     $ 59,196  
  Marketable securities     79,182       91,895  
  Accounts receivable, net     41,962       30,189  
  Inventories, net     22,050       20,707  
  Deferred tax assets     2,841       2,776  
  Refundable income taxes     782       782  
  Prepaid expenses and other current assets     7,476       6,106  
    Total current assets     224,152       211,651  
Restricted cash     435       435  
Property, plant and equipment, net     29,210       35,190  
Goodwill     30,731       30,731  
Intangibles, net     47,326       57,470  
Deferred tax assets     3,983       3,960  
Other assets     1,291       1,271  
    Total assets   $ 337,128     $ 340,708  
LIABILITIES AND STOCKHOLDERS' EQUITY                
Current liabilities:                
  Accounts payable   $ 18,388     $ 16,313  
  Accrued liabilities     17,205       13,985  
  Capital leases, current portion     --       270  
  Income taxes payable     493       172  
  Deferred revenue     7,238       7,030  
    Total current liabilities     43,324       37,770  
Long-term income taxes payable     2,318       2,497  
Deferred tax liabilities     3,029       3,029  
Deferred rent and other liabilities     3,443       3,326  
    Total liabilities     52,114       46,622  
Commitments and contingencies                
Stockholders' equity:                
  Common stock and capital in excess of par value     703,189       695,686  
  Accumulated other comprehensive gain (loss)     213       (249 )
  Accumulated deficit     (418,388 )     (401,351 )
    Total stockholders' equity     285,014       294,086  
    Total liabilities and stockholders' equity   $ 337,128     $ 340,708  
                 
                 

Investor Contact: Stan Finkelstein Investor Relations (925) 290-4321 ir@formfactor.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 342

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 115

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 0

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 157

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 165

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights and Updates on Apax Global Alpha Investments

Updated Category News Views 148

Understanding Apax Global Alpha Limited Apax Global Alpha Limited is a prominent player in the investment sector, recognized for its strategic engagements and robust portfolio. The company, trading under the ticker LSE:INVP, has continuous operations, which not only aim at capital growth but also seek to provide substantial value to stakeholders. Key Information Overview...

Continue Reading
Morgan Stanley's Insights on European Oil and Gas Stock Ratings

Updated Category News Views 187

Morgan Stanley's Updated Ratings on European Oil and Gas Stocks Morgan Stanley has recently updated its ratings on several notable European oil and gas companies, showcasing a mixed but insightful outlook for the sector as we head into 2025. The analysts have raised their overall view of the industry from a cautious stance to 'in-line,' reflecting compelling valuations...

Continue Reading
Defense Metals Corp Secures Funding Through Private Placement

Updated Category News Views 203

Defense Metals Corp Successfully Completes Private Placement Defense Metals Corp. (TSXV: DEFN) is excited to announce the closing of the second and final tranche of its private placement, designed to enhance its financial stability and operational capabilities. This recent tranche has brought in gross proceeds amounting to C$576,000, a notable addition to the ongoing...

Continue Reading
Understanding the Alexandria Real Estate Class Action Lawsuit

Updated Category News Views 193

Overview of the Securities Fraud Class Action The latest class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE) has raised significant concerns among investors. Recently announced, this lawsuit claims violations of federal securities laws amidst a notable decline in stock value, spurred by an impairment charge of $323.9 million. Implications of the...

Continue Reading
Czech Central Bank Poised for Potential Interest Rate Cuts

Updated Category News Views 112

Czech Central Bank's Potential for Rate Easing The Czech central bank finds itself at a pivotal moment as it considers resuming its monetary easing strategy, potentially as soon as next month. Board member Jan Prochazka has shed light on these developments, emphasizing that while easing could be on the table, uncertainties loom due to various domestic and external...

Continue Reading